Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2015-11-17 Declaration of Voting R…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20151117 - Transparency notification of The Capital Group Companies Inc.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a 'Transparency notification' announcing that The Capital Group Companies Inc. has crossed the 10% shareholding threshold in UCB SA/NV. This involves reporting changes in significant share ownership levels by an external entity. This directly corresponds to the definition of Major Shareholding Notification (MRQ). The document explicitly details the new ownership percentage (10.01%) and the date of the change, which is the core function of an MRQ filing.
2015-11-17 English
20151117 - Notification de transparence de The Capital Group Companies Inc.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled "Déclaration de transparence de The Capital Group Companies Inc" and explicitly states that UCB SA received a transparency declaration because The Capital Group Companies Inc. crossed the 10% ownership threshold of UCB SA shares with voting rights. This directly relates to reporting changes in significant share ownership. The filing type corresponding to the notification of changes in significant share ownership levels (crossing thresholds) is Major Shareholding Notification (MRQ). The document is a formal notification of a change in holding, not a general regulatory filing (RNS) or a proxy statement.
2015-11-17 French
20151117 - Transparantieverklaring The Capital Group Companies Inc.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled "Transparantieverklaring" (Transparency Declaration) and explicitly states that UCB NV received a notification from The Capital Group Companies Inc. regarding an acquisition of UCB shares, causing them to cross the 10% threshold. This type of filing, reporting changes in significant share ownership (insider/major shareholder transactions crossing thresholds), directly corresponds to the Major Shareholding Notification category. The document details the exact number of shares held (19,462,506 shares, representing 10.01%) as of November 13, 2015, which is characteristic of a major shareholding disclosure, not a general earnings release (ER) or a full annual report (10-K). It fits the definition of 'Major Shareholding Notification' (MRQ).
2015-11-17 Dutch
UCB 9m 2015_ENG
Interim / Quarterly Report Classification · 100% confidence The document is titled 'UCB Interim Report for the first 9 months of 2015'. It contains detailed financial performance data, including revenue, net sales by product, and updated financial outlooks for the fiscal year. It provides substantive financial analysis and tables comparing 9M 2015 to 9M 2014, which fits the definition of an Interim/Quarterly Report (IR). It is not merely an announcement of a report, as it contains the actual financial data and analysis within the text. 9M 2015
2015-10-28 English
UCB 9m 2015_FR
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first nine months of the fiscal year 2015 (9M 2015). It contains detailed financial data, including revenue, net sales by product, and regional performance tables, as well as management's analysis of business trends, R&D updates, and financial outlook. It is not a mere announcement of a report (RPA) or a short earnings release (ER), as it provides substantive financial analysis and detailed tables. Therefore, it is classified as an Interim/Quarterly Report. 9M 2015
2015-10-28 French
UCB 9m 2015_NL
Interim / Quarterly Report Classification · 95% confidence The document is a press release from UCB titled 'Tussentijdsse resultaten UCB voor de eerste 9 maanden van 2015' (Interim results for the first 9 months of 2015). It provides key financial highlights, revenue figures, R&D updates, and updated financial guidance for the year. It contains substantive financial data and analysis for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2015
2015-10-28 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.